The OS rate of patients with bladder cancer with higher IGF2BP3 expression in tumours was significantly poorer than that of patients with lower IGF2BP3 expression in tumours (P = 0.0277, Figure 1G). The gene discussed is IGF2BP3; the disease is neoplasm.